Literature DB >> 31990596

Emerging concepts on the use of ketamine for chronic pain.

Yunpeng Yang1, Dermot P Maher1, Steven P Cohen1.   

Abstract

Introduction: The use of ketamine infusions for chronic pain has surged, with utilization exceeding the proliferation of knowledge. A proposed mechanism for the long-term benefit in chronic pain is that ketamine may alter the affective-motivational component of pain.Areas covered: In this review, we discuss the classification and various dimensions of pain, and explore the effects of ketamine on different pain categories and components. The relationship between ketamine's action at the NMDA receptor, the development of chronic pain, and the its possible role in preventing the persistence of pain are examined. We also summarize animal models evaluating the antinociceptive effects of ketamine and risk mitigation strategies of ketamine-associated side effects.Expert opinion: Although ketamine exerts most of its analgesic effects via the NMDA receptor, recent evidence suggests that other receptors such as AMPA, and active metabolites such as nor-ketamine, may also play a role in pain relief and alleviation of depression. Data from clinical studies performed in patients with chronic pain and depression, and the observation that ketamine's analgesic benefits outlast its effects on quantitative sensory testing, suggest that the enduring effects on chronic pain may be predominantly due ketamine's ability to modulate the affective-motivational dimension of pain.

Entities:  

Keywords:  Ketamine; chronic pain; complex regional pain syndrome; neuropathic pain; pain management; preclinical studies

Mesh:

Substances:

Year:  2020        PMID: 31990596     DOI: 10.1080/17512433.2020.1717947

Source DB:  PubMed          Journal:  Expert Rev Clin Pharmacol        ISSN: 1751-2433            Impact factor:   5.045


  4 in total

1.  The Increased Channel Activity of N-Methyl-D-Aspartate Receptors at Extrasynaptic Sites in the Anterior Cingulate Cortex of Neonatal Rats Following Prolonged Ketamine Exposure.

Authors:  Jianhui Jin; Ruirui Wang; Qing Lin
Journal:  J Pain Res       Date:  2021-08-08       Impact factor: 3.133

Review 2.  From a Symptom-Based to a Mechanism-Based Pharmacotherapeutic Treatment in Complex Regional Pain Syndrome.

Authors:  Thomas J P Mangnus; Krishna D Bharwani; Maaike Dirckx; Frank J P M Huygen
Journal:  Drugs       Date:  2022-03-05       Impact factor: 11.431

3.  Effect of intravenous low-dose S-ketamine on pain in patients with Complex Regional Pain Syndrome: A retrospective cohort study.

Authors:  Thomas J P Mangnus; Maaike Dirckx; Krishna D Bharwani; Cecile C de Vos; Sander P G Frankema; Dirk L Stronks; Frank J P M Huygen
Journal:  Pain Pract       Date:  2021-07-24       Impact factor: 3.079

Review 4.  Complex Regional Pain Syndrome: A Comprehensive Review.

Authors:  Samantha-Su Taylor; Nazir Noor; Ivan Urits; Antonella Paladini; Monica Sri Sandhu; Clay Gibb; Tyler Carlson; Dariusz Myrcik; Giustino Varrassi; Omar Viswanath
Journal:  Pain Ther       Date:  2021-06-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.